Clinical Trials Logo
  1. Home
  2. Meniere Disease
  3. NCT02529475

Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS) — HYDROPS  

Meniere Disease Clinical Trial

Official title:
Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS)

Clinical Trial Summary

- This prospective study aims to better characterize inner ear's perilymphatic structures with Magnetic Resonance Imaging using contrast media and delayed injection in healthy subjects - MR Perfusion Imaging will be assess in both cochlea as well - Primary auditory brain pathways will be evaluated through MR diffusion imaging

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02529475
Study type Interventional
Source University Hospital, Grenoble
Contact
Status Terminated
Phase Phase 4
Start date February 1, 2016
Completion date September 2020
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04835688 - Ventilation Tube Insertion for Unilateral Menière's Disease N/A
Recruiting NCT05851508 - The Effecttiveness of Intratympanic Methylprednisolon Injections Compared to Placebo in the Treatment of Vertigo Attacks in Meniere's Disease Phase 3
Not yet recruiting NCT05322538 - Menier's Disease - Bone Density Study N/A
Completed NCT05328895 - Transcutaneous Auricular Vagus Nerve Stimulation for Meniere Disease N/A
Completed NCT04569175 - Non Enhanced Labyrinth Imaging for the Detection of Endolymphatic Hydrops in Meniere's Disease "NELI Study" N/A
Not yet recruiting NCT05582148 - Meniere Disease and Hearing Aids N/A
Completed NCT05844657 - Comprehensive Evaluation in Patients With Meniere's Disease
Completed NCT04902963 - What is the Tympanic Membrane Healing Time After Insertion of a Gelfoam PE Tube? N/A
Completed NCT04686695 - Transcutaneous Auricular Vagus Nerve Stimulation Treatment on Meniere Disease N/A
Recruiting NCT04815187 - Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease Phase 4
Recruiting NCT06278129 - Evaluation of the Diagnostic and Prognostic Efficacy of MRI in Acute Sensorineural Hearing Loss and Ménière's Disease
Recruiting NCT04766853 - Verification of the Efficacy/Safety of the Intratympanic Drug Delivery for Hearing Loss Phase 1/Phase 2
Recruiting NCT04370366 - Imaging of Endolymphatic Hydrops at 7T MRI
Enrolling by invitation NCT03520322 - A Study of a Mastoid Device in Subjects With Ménière's Disease N/A
Withdrawn NCT04674735 - Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere's Disease Phase 1
Not yet recruiting NCT05424302 - Effect of Peripheral Vestibular Disease Location on Outcomes Following Home-based Virtual Reality Vestibular Therapy N/A
Recruiting NCT03795675 - CI Following VS Removal or Labyrinthectomy N/A
Completed NCT04218123 - Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes Phase 2/Phase 3
Withdrawn NCT02371798 - Unilateral Meniere Disease: Can Double Dose Gadolinium and Delayed Imaging Make the Diagnosis? N/A
Completed NCT05960786 - Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand N/A